Is Medartis stock undervalued?
No
Medartis is priced for a lot of future growth: you pay CHF 162.49 for every CHF 1 of yearly profit, above 60.
The numbers behind it
Price / earnings (P/E)162.5×Similar companies: 32.6×
Price / free cash flow145.2×What you pay for each CHF 1 of cash it generates in a year
Earnings yield0.6%Yearly profit as a share of the price
Sales growth+13.8% a yearAcross the last yearly reports, up to five years. Fast growth can justify a higher price
How we decide
We compare the price with yearly profit (P/E). Under 15 counts as cheap, 15 to 30 as fair, above 30 as expensive and above 60 as priced for perfection. Free cash flow and growth sit next to it, because a fast grower can deserve a higher price.
More questions about Medartis
Data as of Nov 13, 2026.